TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Addus HomeCare Corporation (ADUS)

Healthcare Medical Care Facilities
115.50 $
-1.0% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Addus HomeCare Corporation.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 3 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet
Momentum & Trend

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Trading Day

Previous Close
116.70$
Open
115.90$
Day High
117.60$
Day Low
114.20$
Volume
154,385shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
88.50 $ 122.80 $
06/03/2026 10/29/2025

Current price 115.50 $ — 79% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
2.2$B
Shares Outstanding
19Mio.
Float
95.1%
Beta
0.9

Performance

Perf. 1M
4.80%
Perf. 3M
3.00%
Perf. 6M
-11.70%
YTD Performance (%)
-10.50%
52-Week-High Distance
-22.2%
Perf. 1Y
8.15%
Perf. 3Y
26.11%
Perf. 5Y
33.06%
Perf. 10Y
512.30%
Perf. Since Inception
1,260.19%

Technical Indicators

MA 38 Days
104.50$
MA 50 Days
101.40$
MA 200 Days
105.50$
RSI (14)
64.5
Volatility 30 Days
24.2%
Volatility 250 Days
31.2%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
21.3
Forward P/E
16.6
PEG
1.1
P/B
1.9
P/S
1.5
EV/EBITDA
13.6
Price/FCF
15.7

Profitability

Gross Margin
32.5%
EBIT Margin
9.4%
Net Margin
6.9%
Return on Equity
9.5%
Return on Assets
6.3%

Balance Sheet & Safety

Equity Ratio
77.7%
Debt/Equity
0.1
fortress balance sheet
Altman Z″
9.29
very solid
Piotroski
8 out of 9

Growth

Sales Growth Last Quarter
7.70%
EPS Growth Last Quarter
17.20%
Sales Growth (Year)
23.21%
Forward Sales Growth
4.77%
Forward EPS Growth
6.90%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
4
RS Rating
23
EPS Rating
63
very solid
Piotroski
8 out of 9
Fundamental Rating
B (58 out of 100)
fortress balance sheet
Altman Z″
9.29

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 115.50 $
Price Target (average) 133.00 $

The price target sits 15.2% above the current price.

Consensus
Sell
Analyst Ratings
11
Distribution of Recommendations
Strong Buy 7
Buy 3
Hold 0
Sell 1
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 7.00 6.85 – 7.15 1,518 12.4% 14
12/31/2027 7.48 7.15 – 7.64 1,590 6.9% 14

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

3. Aug 2026 · after the close · Q2 2026
Expected Earnings per Share
1.51 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 297.1 $M Q4 2025: Q1 · 337.7 $M Q1 2025: Q2 · 349.4 $M Q2 2025: Q3 · 362.3 $M Q3 2025: Q4 · 373.1 $M Q4 2026: Q1 · 363.6 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 1.07 -11.10 297 7.50 6.60 10 9
2025: Q1 1.15 19.30 338 20.30 6.30 19 17
2025: Q2 1.20 9.70 349 21.80 6.30 23 21
2025: Q3 1.24 12.60 362 25.00 6.30 51 49
2025: Q4 1.61 51.30 373 25.60 8.00 19 16
2026: Q1 1.36 17.50 364 7.70 6.90 52 51
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 401 15 12 1.04 -1 159 231
2017 426 25 14 1.17 53 176 267
2018 518 23 18 1.33 33 276 355
2019 649 35 25 1.62 12 476 637
2020 765 45 33 2.08 109 519 893
2021 865 66 45 2.81 39 574 948
2022 951 69 46 2.84 105 634 938
2023 1,059 91 63 3.83 112 707 1,024
2024 1,155 103 74 4.23 116 970 1,413
2025 1,423 139 96 5.20 112 1,085 1,437

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

Addus HomeCare Corporation bietet gemeinsam mit ihren Tochtergesellschaften Körperpflegedienste für ältere, chronisch kranke und behinderte Menschen sowie Personen mit Hospitalisierungs- oder Institutionalisierungsrisiko in den USA an. Das Unternehmen ist in drei Segmenten tätig: Personal Care,…

Employees5,982
HeadquartersFrisco, TX
Address6303 Cowboys Way, 75034 Frisco, United States
Phone469 535 8200
Websiteaddus.com
IPO Date28. Oct 2009
ISINUS0067391062

Management

Management
Name Title Birth Year
R. Dirk Allison CPA CEO & Chairman of the Board 1956
Heather Dixon CPA President & COO 1972
Brian W. Poff CFO, Executive VP, Secretary & Treasurer 1974
Sean P. Gaffney J.D. Executive VP & Chief Legal Officer 1980
Darby Anderson Executive VP & Chief Government Relations Officer 1966
Zach Simpson Senior VP & Chief Accounting Officer
Michael D. Wattenbarger Executive VP & Chief Information Officer 1971
Monica Raines J.D. Executive VP and Chief Compliance & Quality Officer 1980
Roberton James Stevenson Executive VP & Chief Human Resource Officer 1981
Diane Kumarich Senior Vice President of Payor Innovation

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
21. Apr 2026 Cliff Donald Blessing EVP Sell 178 93.61 16,663

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?